Impact of Louisiana’s HPV Vaccine Awareness Policy on HPV Vaccination Among 13- to 17-Year-Old Females

Abstract

The Advisory Committee on Immunization Practices recommends routine human papillomavirus (HPV) immunization for 11- to 12-year-old adolescents. In 2008, Louisiana required the school boards to distribute HPV vaccine information to parents or guardian of students in Grades 6 to 12. This article investigates the impact of this policy on HPV vaccination among 13- to 17-year-old female adolescents using National Immunization Survey-Teen (NIS-Teen) data. Drawing on the data from the 2008 to 2012 NIS-Teen, we compared the difference in proportions of females who have been vaccinated before and after the policy. Using difference-indifference estimation, we explored the change in vaccination rates before and after the policy implementation in Louisiana compared with Alabama and Mississippi, two states that did not have such a policy in place. The difference-in-differences estimates for HPV vaccination were not significant. Physician recommendation for HPV vaccination was significantly associated with vaccination among females in Louisiana and Alabama (adjusted odds ratio [aOR] = 7.74; 95% confidence interval [CI; 5.22, 11.5]), and for those in Louisiana and Mississippi (aOR = 7.05; 95% CI [4.6, 10.5]). Compared to the proportion of female adolescents who had received physician recommendation in Alabama or Mississippi, the proportion in Louisiana did not increase significantly in the postpolicy period. HPV vaccination rates did not increase significantly in Louisiana compared to Alabama or Mississippi following the implementation of the policy. Despite Louisiana’s policy, physician recommendation remains the key determinant of HPV vaccination. HPV vaccine awareness does not necessarily result in HPV vaccination.

Keywords

adolescent health health policy health promotion health protective behavior HPV vaccination

Get full access to this article

View all access options for this article.

References

Bartlett

J. A.

Peterson

J. A.

(2011). The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: A review of the literature. Journal of School Nursing, 27, 434-446. doi:10.1177/1059840511415861

Casciotti

D. M.

Smith

K. C.

Andon

Vernick

Tsui

Klassen

A. C.

(2014). Print news coverage of school-based human papillomavirus vaccine mandates. Journal of School Health, 84, 71-81. doi:10.1111/josh.12126

Centers for Disease Control and Prevention. (2012). Advisory Committee on Immunization Practices: Human papillomavirus vaccine resolution. Retrieved from http://www.cdc.gov/vaccines/programs/vfc/providers/resolutions.html

Centers for Disease Control and Prevention. (2016). Vaccines for children program. Retrieved from http://www.cdc.gov/vaccines/programs/vfc/index.html

Centers for Disease Control and Prevention & National Centers for Health Statistics. (2013). National Immunization Survey–Teen: A user’ s guide for the 2011 public-use data file. Retrieved from http://www.cdc.gov/nchs/nis/data_files_teen.htm

Curtin

L. R.

Mohadjer

L. K.

Dohrmann

S. M.

Kruszan-Moran

Mirel

L. B.

Carroll

M. D.

. . . Johnson

C. L.

(2013). National Health and Nutrition Examination Survey: Sample design, 2007-2010. Vital and Health Statistics, 2(160), 1-32.

Descy

Tessaring

(2004). Evaluation and impact of education and training: The value of learning. Luxembourg: Office for Official Publications of the European Communities Retrieved from http://www.trainingvillage.gr/etv/projects_Networks/researchlab/

Dorell

Stokley

Yankey

Jeyarajah

MacNeil

Markowitz

L. E.

(2012). National and State vaccination coverage among adolescents aged 13-17 Years—United States, 2011. Morbidity and Mortality Weekly Report, 61, 671-677.

Fishman

Taylor

Kooker

Frank

(2014). Parent and adolescent knowledge of HPV and subsequent vaccination. Pediatrics, 134, e1049-e1056. doi:10.1542/peds.2013-3454

10.

Gerend

M. A.

Lee

S. C.

Shepherd

J. E.

(2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34, 468-471. doi:10.1097/01.olq.0000245915.38315.bd

11.

Gilkey

M. B.

Moss

J. L.

Mcree

Brewer

N. T.

(2012). Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine, 30, 5928-5934. doi:10.1016/j.vaccine.2012.07.045

12.

Golden

S. D.

Moracco

K. E.

Feld

A. L.

Turner

K. L.

DeFrank

J. T.

Brewer

N. T.

(2014). Process evaluation of an intervention to increase provision of adolescent vaccines at school health centers. Health Education & Behavior, 41, 625-632. doi:10.1177/1090198114531773

13.

Joseph

N. P.

Clark

J. A.

Bauchner

Walsh

J. P.

Mercilus

Figaro

. . . Perkins

R. B.

(2012). Knowledge, attitudes, and beliefs regarding HPV vaccination: Ethnic and cultural differences between African-American and Haitian immigrant women. Women’s Health Issues, 22, e571-e579. doi:10.1016/j.whi.2012.09.003

14.

Kaplan

D. W.

(2010). Barriers and potential solutions to increasing immunization rates in adolescents. Journal of Adolescent Health, 46, S24-S33. doi:10.1016/j.jadohealth.2009.12.004

15.

Laugesen

M. J.

Mistry

Carameli

K. A.

Ribisl

K. M.

Needleman

Bastani

(2014). Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010. Journal of Adolescent Health, 55, 659-664. doi:10.1016/j.jadohealth.2014.04.015

16.

Louisiana State Legislature. (2008). Lousiana House Bill 359. Retrieved from http://www.legis.la.gov/legis/BillInfo.aspx?s=08RS&b=ACT210&sbi=y

17.

Markowitz

L. E.

Hariri

Lin

Dunne

E. F.

Steinau

McQuillan

Unger

E. R.

(2013). Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. Journal of Infectious Diseases, 208, 385-393. doi:10.1093/infdis/jit192

18.

Mason

Sutton

Whittaker

McSweeney

Millar

Donmall

. . . Pierce

(2015). The impact of paying treatment providers for outcomes: Difference-in-differences analysis of the “payment by results for drugs recovery” pilot. Addiction, 110, 1120-1128. doi:10.1111/add.12920

19.

Meyer

B. D.

(1995). Natural and quasi-experiments in economics. Journal of Business & Economic Statistics, 13, 151-161. doi:10.2307/1392369

20.

Mississippi Legislature. (2016). House Bill No. 999. Retrieved from http://www.legislature.ms.gov/Pages/default.aspx

21.

National Centers for Health Statistics. (2013). Datasets for the National Immunization Survey–Teen. Retrieved from http://www.cdc.gov/nchs/nis/data_files_teen.htm

22.

National Conference of States Legislatures. (2015). HPV vaccine: State legislation and statutes. Retrieved from http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx

23.

Next 10. (2015). Foreign-born population 2005-2014. Retrieved from http://www.compare50.org/chart/category/96/sub_category/387/display/427/chart/434/type/1/states/53,71,77

24.

Patel

M. S.

Volpp

K. G.

Small

D. S.

Hill

A. S.

Even-Shoshan

Rosenbaum

. . . Silber

J. H.

(2014). Association of the 2011 ACGME resident duty hour reforms with mortality and readmissions among hospitalized medicare patients. Journal of the American Medical Association, 312, 2364-2373. doi:10.1001/jama.2014.15273

25.

Petticrew

Cummins

Ferrell

Findlay

Higgins

Hoy

. . . Sparks

(2005). Natural experiments: an underused tool for public health? Public Health, 119, 751-757. doi:10.1016/j.puhe.2004.11.008

26.

Pierre-Victor

Mukherjee

Bahelah

Madhivanan

(2014). Human papillomavirus vaccine uptake among males11-26 years in United States: Findings from the national health and nutrition examination survey, 2011-2012. Vaccine, 32, 6655-6658. doi:10.1016/j.vaccine.2014.09.044

27.

Rajaram

Chung

J. W.

Jones

A. T.

Cohen

M. E.

Dahlke

A. R.

C. Y.

. . . Bilimoria

K. Y.

(2014). Association of the 2011 ACGME resident duty hour reform with general surgery patient outcomes and with resident examination performance. Journal of the American Medical Association, 312, 2374-2384. doi:10.1001/jama.2014.15277

28.

Reagan-Steiner

Yankey

Jeyarajah

Elam-Evans

L. D.

Singleton

J. A.

Curtis

C. R.

. . . Stokley

(2015). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17—United States, 2014. Morbidity and Mortality Weekly Report, 64, 784-792. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26225479

29.

Reiter

P. L.

Katz

M. L.

Paskett

E. D.

(2013). Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate. Vaccine, 31, 3121-3125. doi:10.1016/j.vaccine.2013.04.068

30.

Remler

D. K.

Van Ryzin

G. G.

(2011). Natural and quasi experiments. In Remler

D. K.

Van Ryzin

G. G.

(Eds.), Research methods in practice: Strategies for description and causation (pp. 427-464). Thousand Oaks, CA: Sage.

31.

Rudowitz

Artiga

Musumeci

(2014). The ACA and Secent Section 1115 Medicaid demonstration waivers. Retrieved from https://kaiserfamilyfoundation.files.wordpress.com/2014/02/8551-the-aca-and-recent-section-1115-medicaid-demonstration-waivers.pdf

32.

StataCorp. (2013). Stata Statistical Software: Release 13. College Station, TX: Author.

33.

Stephens

D. P.

Thomas

T. L.

(2013). Cultural values influencing immigrant Haitian mothers’ attitude toward human papillomavirus vaccination for daughters. Journal of Black Psychology, 39, 156-168. doi:10.1016/j.biotechadv.2011.08.021.Secreted

34.

U.S. Department of Health & Human Services. (2014). Healthy People 2020. Washington, DC: Author. Retrieved from http://www.healthypeople.gov/2020/about/default.aspx

35.

U.S. Department of Health & Human Services & Centers for Disease Control and Prevention. (2016). Selected STDs by age, race/ethnicity, and gender, 1996-2013. Retrieved from http://wonder.cdc.gov/std-v2013-race-age.html

36.

U.S. Food and Drug Administration. (2014). Press announcements: FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm

37.

Vadaparampil

S. T.

Malo

T. L.

Kahn

J. A.

Salmon

D. A.

Lee

J.-H.

Quinn

G. P.

. . . Giuliano

A. R.

(2014). Physicians’ human papillomavirus vaccine recommendations, 2009 and 2011. American Journal of Preventive Medicine, 46(1), 80-84. doi:10.1016/j.amepre.2013.07.009

38.

Wimberley

R. C.

(2008). Sociology with a Southern face: Why are we sociologists and what are we doing about it in the south. Social Forces, 86, 881-909.